New drug shows strong results against stubborn mutation

June 5, 2019 | Michael Easterling

A new drug being investigated by Marwan Fakih, M.D., professor in the Department of Medical Oncology & Therapeutics Research and medical director of the Judy & Bernard Briskin Center for Clinical Research, is "potentially practice-changing," Fakih said.

Continue Reading

Leading City of Hope hematologists appointed to new positions

June 21, 2019 | Letisia Marquez

Two breakthrough technologies — stem cell transplants and CAR T cell therapy — can work together to help more leukemia patients than ever before, including many who have exhausted all other options.

Core connection: Nuclear Magnetic Resonance (NMR) Core

June 20, 2019 | Katie Neith

High-resolution nuclear magnetic resonance (NMR) spectroscopy can characterize the structure, dynamics, reaction state and chemical environment of biomolecules.

Steven Rosen inducted into the Association of American Physicians

June 19, 2019 | Michael Easterling

Provost and Chief Scientific Officer Steven T. Rosen, M.D., the Irell & Manella Cancer Center Director’s Distinguished Chair, has been inducted as a member of the Association of American Physicians (AAP). Membership to the AAP is bestowed upon those physicians who indicate a "pre-eminence and the highest caliber of physician-led science accomplishments and scientific leadership."

Immunotherapy combo could tackle advanced cancers

June 18, 2019 | Zen Vuong

City of Hope physician-scientists recently opened two clinical trials to investigate a combination of cytokines and immunotherapy that may be able to transform nearly impossible-to-treat cancer into a disease that can be corralled into remission.

Scientist honored for 'digging into the DNA of cancer'

June 17, 2019 | City of Hope

Dr. Jianjun Chen was recently named the Simms/Mann Family Foundation Chair in Systems Biology. Chen was recognized with the endowment for his leading-edge cancer research that is founded in personalized, gene-based medicine.

Study: A1c test misses most cases

June 13, 2019 | City of Hope

The hemoglobin A1c blood test is widely used to diagnose type 1 and type 2 diabetes but it is actually unable to detect the disease in most patients, according to a new study presented March 23 at the Endocrine Society’s annual meeting.

City of Hope investigator awarded $1 million ORIEN NOVA Grant

June 11, 2019 | Maxine Nunes

The dynamic young founder and director of City of Hope’s Precision Imaging Lab, Ammar Chaudhry, M.D., is one of the first recipients of the new ORIEN NOVA Award. The $1 million grant will fund research for his breakthrough approach to cancer imaging and diagnosis.

New drug shows strong results against stubborn mutation

June 5, 2019 | Michael Easterling

A new drug being investigated by Marwan Fakih, M.D., professor in the Department of Medical Oncology & Therapeutics Research and medical director of the Judy & Bernard Briskin Center for Clinical Research, is "potentially practice-changing," Fakih said.